The purposes of this article are to briefly review the adverse reactions induced by antipsychotics that have the greatest modicolegal implications and to set them in the context of pharmacist liability for patient injury. Although little or no case law has evolved specifying antipsychotic drugs and the pharmacist's possible duty to warn, such an obligation may be increasingly realized as standards of practice in psychiatric pharmacy are elevated.
Get full access to this article
View all access options for this article.
References
1.
Ereshefsky L., Richards A.: Psychoses, in Young LY, Koda-Kimble MA (eds): Applied Therapeutics: The Clinical Use of Drugs, (ed 4). Vancouver, WA, Applied Therapeutics, Inc, 1988, pp 1189-1230
2.
NIMH Psychopharmacology Service Center Collaborative Study Group: Phenothiazine treatment in acute schizophrenia: Effectiveness. Arch Gen Psychiatry10:246-260, 1964
Crane GE: Tardive dyskinesia and related neurological disorders, in Iversen LL (ed): Handbook of Psychopharmacology , vol 10. New York, NY, Plenum, pp 165-184, 1978
5.
DeVeaugh-Geiss J.: Epidemiology of tardive dyskinesia: Part I, in DeVeaugh-Geiss J (ed): Tardive Dyskinesia and Related Involuntary Movement Disorders. Boston, MA , Wright PSG, 1982, pp 33-50
6.
Marsden CD: The pathophysiology of extrapyramidal side effects of neuroleptic drugs. Psychol Med10:55-63, 1980